Cargando…

Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy

Background and study aims  Response evaluation criteria in solid tumors (RECIST) have been the gold standard to preoperatively predict treatment response and prognosis in patients with gastric cancer (GC) after neoadjuvant chemotherapy (NAC); however, methods for patients without evaluable lesions b...

Descripción completa

Detalles Bibliográficos
Autores principales: Shoji, Yoshiaki, Nunobe, Souya, Nishie, Naoki, Yagi, Shusuke, Makuuchi, Rie, Ida, Satoshi, Kumagai, Koshi, Ohashi, Manabu, Ishiyama, Akiyoshi, Yoshio, Toshiyuki, Hirasawa, Toshiaki, Fujisaki, Junko, Sano, Takeshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2022
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759937/
https://www.ncbi.nlm.nih.gov/pubmed/35047336
http://dx.doi.org/10.1055/a-1635-5855
_version_ 1784633213497376768
author Shoji, Yoshiaki
Nunobe, Souya
Nishie, Naoki
Yagi, Shusuke
Makuuchi, Rie
Ida, Satoshi
Kumagai, Koshi
Ohashi, Manabu
Ishiyama, Akiyoshi
Yoshio, Toshiyuki
Hirasawa, Toshiaki
Fujisaki, Junko
Sano, Takeshi
author_facet Shoji, Yoshiaki
Nunobe, Souya
Nishie, Naoki
Yagi, Shusuke
Makuuchi, Rie
Ida, Satoshi
Kumagai, Koshi
Ohashi, Manabu
Ishiyama, Akiyoshi
Yoshio, Toshiyuki
Hirasawa, Toshiaki
Fujisaki, Junko
Sano, Takeshi
author_sort Shoji, Yoshiaki
collection PubMed
description Background and study aims  Response evaluation criteria in solid tumors (RECIST) have been the gold standard to preoperatively predict treatment response and prognosis in patients with gastric cancer (GC) after neoadjuvant chemotherapy (NAC); however, methods for patients without evaluable lesions by RECIST are not yet confirmed. The aim of this study was to assess the utility of preoperative endoscopy for predicting treatment response and prognosis in patients with GC after NAC. Patients and methods  This retrospective study included 105 patients with initially resectable GC who underwent NAC followed by surgical treatment. Preoperative factors for predicting treatment response and survival outcomes were analyzed. Results  The number of patients classified as responders using preoperative endoscopic assessment, RECIST, and postoperative pathological evaluation were 25 (23.8 %), 28 (26.7 %), and 18 (17.1 %), respectively. Forty-three patients (41 %) were classified as non-targeted disease only, and their treatment responses were not evaluable by RECIST. Multivariate analysis identified endoscopic response as an independent preoperative factor to predict postoperative histological treatment response (odds ratio = 4.556, 95 % CI = 1.169–17.746, P  = 0.029). Endoscopic treatment response was the only independent preoperative predictive factor for overall survival (OS) (hazard ratio = 0.419, 95 % confidence interval (CI) = 0.206–0.849, P  = 0.016). Further, endoscopic treatment response was available for 33 patients (76.7 %) with non-targeted disease only, which showed significantly different OS between endoscopic responders (80.0 %) and non-responders (43.5 %) ( P  = 0.025). Conclusions  Endoscopic evaluation was an independent preoperative factor to predict treatment response and prognosis in patients with GC after NAC. Endoscopic assessment may be especially valuable for patients who could not be assessed by RECIST.
format Online
Article
Text
id pubmed-8759937
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-87599372022-01-18 Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy Shoji, Yoshiaki Nunobe, Souya Nishie, Naoki Yagi, Shusuke Makuuchi, Rie Ida, Satoshi Kumagai, Koshi Ohashi, Manabu Ishiyama, Akiyoshi Yoshio, Toshiyuki Hirasawa, Toshiaki Fujisaki, Junko Sano, Takeshi Endosc Int Open Background and study aims  Response evaluation criteria in solid tumors (RECIST) have been the gold standard to preoperatively predict treatment response and prognosis in patients with gastric cancer (GC) after neoadjuvant chemotherapy (NAC); however, methods for patients without evaluable lesions by RECIST are not yet confirmed. The aim of this study was to assess the utility of preoperative endoscopy for predicting treatment response and prognosis in patients with GC after NAC. Patients and methods  This retrospective study included 105 patients with initially resectable GC who underwent NAC followed by surgical treatment. Preoperative factors for predicting treatment response and survival outcomes were analyzed. Results  The number of patients classified as responders using preoperative endoscopic assessment, RECIST, and postoperative pathological evaluation were 25 (23.8 %), 28 (26.7 %), and 18 (17.1 %), respectively. Forty-three patients (41 %) were classified as non-targeted disease only, and their treatment responses were not evaluable by RECIST. Multivariate analysis identified endoscopic response as an independent preoperative factor to predict postoperative histological treatment response (odds ratio = 4.556, 95 % CI = 1.169–17.746, P  = 0.029). Endoscopic treatment response was the only independent preoperative predictive factor for overall survival (OS) (hazard ratio = 0.419, 95 % confidence interval (CI) = 0.206–0.849, P  = 0.016). Further, endoscopic treatment response was available for 33 patients (76.7 %) with non-targeted disease only, which showed significantly different OS between endoscopic responders (80.0 %) and non-responders (43.5 %) ( P  = 0.025). Conclusions  Endoscopic evaluation was an independent preoperative factor to predict treatment response and prognosis in patients with GC after NAC. Endoscopic assessment may be especially valuable for patients who could not be assessed by RECIST. Georg Thieme Verlag KG 2022-01-14 /pmc/articles/PMC8759937/ /pubmed/35047336 http://dx.doi.org/10.1055/a-1635-5855 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Shoji, Yoshiaki
Nunobe, Souya
Nishie, Naoki
Yagi, Shusuke
Makuuchi, Rie
Ida, Satoshi
Kumagai, Koshi
Ohashi, Manabu
Ishiyama, Akiyoshi
Yoshio, Toshiyuki
Hirasawa, Toshiaki
Fujisaki, Junko
Sano, Takeshi
Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy
title Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy
title_full Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy
title_fullStr Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy
title_full_unstemmed Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy
title_short Impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy
title_sort impact of preoperative endoscopy for predicting treatment response and prognosis in patients with gastric cancer after neoadjuvant chemotherapy
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8759937/
https://www.ncbi.nlm.nih.gov/pubmed/35047336
http://dx.doi.org/10.1055/a-1635-5855
work_keys_str_mv AT shojiyoshiaki impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy
AT nunobesouya impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy
AT nishienaoki impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy
AT yagishusuke impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy
AT makuuchirie impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy
AT idasatoshi impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy
AT kumagaikoshi impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy
AT ohashimanabu impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy
AT ishiyamaakiyoshi impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy
AT yoshiotoshiyuki impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy
AT hirasawatoshiaki impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy
AT fujisakijunko impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy
AT sanotakeshi impactofpreoperativeendoscopyforpredictingtreatmentresponseandprognosisinpatientswithgastriccancerafterneoadjuvantchemotherapy